[Mechanism of action of Ginkgo biloba extract in experimental cerebral edema].
Oedema is one of the major complication of cerebral ischaemia being at the same time a consequence and an aggravating factor. Its first phase is intracellular and cytotoxic, with breakdown of ionic pumps through loss of energy, resulting in a whole sequence of ionic perturbations characterized by loss of intracellular K+ and accumulation of water and Na+, Cl-, and Ca2+ ions in the cells of the ischaemic zone. The second phase, termed vasogenic, applies to the accumulation of lactates, inorganic phosphates and free polyunsaturated fatty acids and in particular, arachidonic acid. This last compound is responsible for the production of membrane "aggressors", amongst which free radicals play an important rôle. Ginkgo biloba extract limits the formation of cerebral oedema and suppresses its neurological consequences, whether the oedema is of cytotoxic (triethyltin) or vasogenic (unilateral traumatic oedema) origin. Several membrane mechanisms could be implicated in the protective action manifested by Ginkgo biloba extract against cerebral oedema.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D010936:Plant Extracts / Q000627:therapeutic use; D010946:Plants, Medicinal; D011817:Rabbits; D051381:Rats; D014197:Trees; D014267:Triethyltin Compounds / Q000633:toxicity
D010936:Plant Extracts; D014267:Triethyltin Compounds
Mécanismes d'action de l'extrait de Ginkgo biloba sur l'oedème cérébral expérimental.